Silo pharma licenses novel peptide-guided drug delivery approach for the treatment of ms

Targeting innovative treatments for multiple sclerosis and other neuroinflammatory pathology targeting innovative treatments for multiple sclerosis and other neuroinflammatory pathology

SILO Ratings Summary

SILO Quant Ranking